Category: News

DRI Healthcare Trust Reports Second Quarter 2024 Results

Highest Normalized Total Cash Receipts in a single quarter since IPO, excluding milestones Trust internal investigation substantially complete with no impact to cash royalty receipt New executive leadership in place and in-depth review of governance practices underway TORONTO, Aug. 6, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or the “Trust”) today […]

DRI Healthcare Trust and DRI Capital Inc. Announce Executive Changes

TORONTO, July 8, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the “Trust”) and DRI Capital Inc. (“DRI Healthcare”), the manager of the Trust, today announced changes to their respective senior executive teams.  The Board of Trustees of the Trust (the “Board”) has appointed Gary Collins as the interim CEO of the Trust in addition to his role as Chair […]

DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

– Transaction pushes total committed capital to over US$1 billion since IPO – – Second Xenpozyme royalty increases exposure to rare diseases – – Long-term asset further increases portfolio duration – TORONTO, July 2, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust"), a global leader in providing financing to advance innovation in […]

DRI Healthcare Trust Announces Voting Results of AGM

TORONTO, May 7, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") is pleased to announce results of voting at its annual general meeting ("AGM") of unitholders held on May 7, 2024. All of the nominees for election as trustees of the Trust referred to in its management information circular dated March […]

DRI Healthcare Trust Reports First Quarter 2024 Results

– Highest quarterly Adjusted EBITDA since IPO underscores continued execution of growth strategy –  – Omidria expansion transaction highlights strong execution capabilities – – Simplifying capital structure with preferred securities refinancing optimizes cost of capital – TORONTO, May 6, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX:DHT.U) ( the "Trust") today announced its financial […]

DRI Healthcare Trust Closes Previously Announced Refinancing of Preferred Securities

– Transaction significantly reduces potential dilution with a net reduction of warrants equivalent to 8.2% of units outstanding – TORONTO, April 23, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces the closing of its previously announced preferred securities refinancing, whereby its US$114,760,000 aggregate principal amount of Series A and Series B […]

DRI Healthcare Trust Announces Refinancing of Preferred Securities

– Transaction reduces the Trust’s potential unit dilution by 8.2% by retiring in-the-money warrants and replacing them with out-of-the-money warrants – TORONTO, April 15, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (the "Trust") announces the refinancing of its US$114,760,000 aggregate principal amount of Series A and Series B preferred securities and 6,369,180 […]

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, March 26, 2024 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) ( TSX: DHT.U) ("DRI" or the "Trust"), a global leader in providing financing to advance innovation in the life sciences industry, today announced that the Trust will participate in the following investor conferences in April and May: 2024 Bloom Burton & Co. Healthcare Investor […]